PCM
TMO icon

Permanent Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Permanent Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-511
Closed -$245K – 220
2026
Q1 		$245K Buy
511
+29
+6% +$15.7K 0.04% 137
2025
Q4 		$280K Sell
482
-162
-25% -$91.6K 0.05% 113
2025
Q3 		$313K Buy
+644
New +$300K 0.06% 109
2025
Q1 		$363K Buy
729
+3
+0.4% +$1.63K 0.1% 44
2024
Q4 		$378K Buy
+726
New +$399K 0.12% 40
2024
Q2 		$261K Buy
+644
New +$369K 0.05% 119

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Permanent Capital Management's TMO Position: Q2 2026 in Review

Permanent Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 511 shares — an estimated $245K sold.

Permanent Capital Management first reported a position in TMO in Q2 2024 and held it in 6 quarters. The position peaked at $378K in Q4 2024. 2,628 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Permanent Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Permanent Capital Management sold 511 Thermo Fisher Scientific shares in Q2 2026, an estimated $245K.
  • Permanent Capital Management first reported a position in Thermo Fisher Scientific in Q2 2024 and held it in 6 quarters.
  • Permanent Capital Management's Thermo Fisher Scientific position peaked at $378K in Q4 2024.
  • 2,628 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Permanent Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.